Back to search

Article

Rational Design of the Remdesivir Binding Site in the RNA-dependent RNA Polymerase of SARS-CoV-2: Implications for Potential Resistance

2020-06-29

Abstract excerpt

<h4>ABSTRACT</h4> SARS-CoV-2 is rapidly evolving with the continuous emergence of new mutations. There is no specific antiviral therapy for COVID-19, and the use of Remdesivir for treating COVID-19 will likely continue before clinical trials are completed. Due to the lengthening pandemic and evolving nature of the virus, predicting potential residues prone to mutations is crucial for the management of Remdesivir...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
de1f0009-564b-552d-8e5a-04a8d5d3e83e
DOI
10.1101/2020.06.27.174896
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Rational Design of the Remdesivir Binding Site in the RNA-dependent RNA Polymerase of SARS-CoV-2: Implications for Potential ResistanceDOI 10.1101/2020.06.27.174896
Select a neighboring publication to make it the new centre.